Related Experiment Video
Updated: Apr 12, 2026

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Published on: September 20, 2021
The Current State of Vaccine Development for Ocular HSV-1 Infection
D J Royer1, A Cohen2, Djj Carr3
1Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center.
Abstract:
HSV-1 continues to be the leading cause of infectious corneal blindness. Clinical trials for vaccines against genital HSV infection have been ongoing for more than three decades. Despite this, no approved vaccine exists, and no formal clinical trials have evaluated the impact of HSV vaccines on eye health. We review here the current state of development for an efficacious HSV-1 vaccine and call for involvement of ophthalmologists and vision researchers.
Related Concept Videos
Cytomegalovirus Disease
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Vaccine Production

